Table of Contents
- 2021 Global Fund Results Report (English and Français)
- Executive Summary (English and Français)
- Press Release (English and Français)
Results at a Glance
Feature Film: We Can't Go Backwards
Multimedia Resources: Graphics
Social Media Messages
Global Fund at 20
The COVID-19 pandemic had a devastating impact on the fight against HIV, TB and malaria in 2020. For the first time in the Global Fund’s history, key programmatic results for HIV, TB and malaria declined.
The Global Fund partnership’s rapid and determined response to COVID-19 prevented an even worse outcome. The Global Fund responded quickly and at scale to the new pandemic, mobilizing and approving an additional US$3.3 billion as of August 2021 to more than 100 countries to fight COVID-19, protect front-line workers, and adapt lifesaving HIV, TB and malaria programs.
Decades of experience in fighting HIV, TB and malaria prepared many low- and middle-income countries in the Global Fund partnership to quickly respond to COVID-19, using the same laboratories, disease surveillance, community networks, trained health workers and supply chains that were created to fight HIV, TB and malaria.
COVID-19 has catalyzed a multitude of health innovations that must be scaled up to regain lost ground against HIV, TB and malaria, such as co-testing for infectious diseases, multi-month dispensing of medicine, and digital tools for prevention activities and treatment support.
To regain lost ground and prevent COVID-19 from having a catastrophic long-term impact on HIV, TB and malaria – and to defeat COVID-19 itself – we must scale up investments to fight all four diseases at once, and expand innovations and adaptation measures now.
The Global Fund was created 20 years ago to fight the world’s three deadliest epidemics: HIV, TB and malaria. Global Fund-supported programs have saved 44 million lives since 2002, proof that global commitment and community leadership can force the world’s deadliest infectious diseases into retreat.
Results at a Glance
21.9 million people received lifesaving antiretroviral therapy for HIV in 2020 – an 8.8% increase compared to 2019 despite COVID-19.
8.7 million people reached with HIV prevention services in 2020 – an 11% decrease from 2019 due to COVID-19.
188 million mosquito nets distributed to protect families from malaria in 2020 – a 17% increase compared to 2019 despite COVID-19.
4.7 million people treated for tuberculosis in 2020 – an 18% decrease compared to 2019 due to COVID-19.
194,000 children in contact with TB patients received preventative therapy in 2020 – a 13% increase compared to 2019 despite COVID-19.
In 2020, the Global Fund disbursed US$4.2 billion to support countries to fight HIV, TB and malaria. In addition to this core funding, the Global Fund also approved US$980 million in 2020 to respond to COVID-19, protect front-line health workers, and mitigate the impact on HIV, TB and malaria programs.
As of August 2021, we have approved a total of US$3.3 billion to 107 countries and 16 multicounty programs for COVID-19.
Download additional key messages and talking points to learn more:
- Results: HIV
- Results: Tuberculosis
- Results: Malaria
- Resilient and Sustainable Systems for Health
- Investing for Impact
- Fighting COVID-19
Multimedia Content and Social Media Messages
The @GlobalFund 2021 Results Report is now available. Working together the Global Fund partnership has saved 44 MILLION lives since 2002.
Working together @GlobalFund partnership has saved 44 MILLION lives since 2002. But for the first time in Global Fund history, key programmatic results for HIV, TB and malaria declined. #COVID19 is derailing progress. We cannot let that happen.
Since 2002, the @GlobalFund partnership has saved 44 million lives. To protect the progress achieved in the fight against HIV, TB and malaria and save lives, we must see the fights against COVID-19, HIV, TB and malaria as one and the same fight.
The @GlobalFund 2021 Results Report is now available. In 2020, the Global Fund deployed US$4.2 BILLION to fight HIV, TB and malaria.
New @GlobalFund Results: 4.7 MILLION people received lifesaving TB medicine in 2020 – a drop of 18% (or around 1 million patients) compared to 2019. #COVID19 is having a devastating impact on the fight against TB. We cannot let this continue.
New @GlobalFund Results: 188 MILLION mosquito nets distributed to protect families from malaria in 2020. Despite #COVID19 disruptions, community health workers have led the way in adapting programs to continue the fight against malaria.
New @GlobalFund Results: 21.9 MILLION people received lifesaving HIV medicine in 2020. But #COVID19 is rolling back our progress, especially for vulnerable populations. Testing for HIV fell 22% in 2020. We cannot let that happen.
DYK? @GlobalFund mobilized and approved US$3.3 BILLION (Mar 2020 - Aug 2021) to fight #COVID19 in over 100 countries – protecting front-line workers and adapting HIV, TB and malaria programs to #LeaveNoOneBehind.
Global Fund at 20
This year, the Global Fund celebrates 20 years of making the impossible possible.
Twenty years ago, AIDS, tuberculosis and malaria looked unbeatable. Year after year, the world’s deadliest epidemics were claiming millions of lives with devastating consequences for families and communities around the world, especially in poor countries.
We refused to accept that story.
The Global Fund was born out of an unwillingness to accept the status quo. That spirit of optimism, persistence and purpose has defined the achievements of the last 20 years and helped unite world leaders, communities, civil society, health workers and the private sector to fight AIDS, tuberculosis, and malaria.
But as we celebrate 20 years of progress, COVID-19 is destroying many hard-fought gains in the fight against HIV, TB and malaria, and putting millions more people at risk. Once again, we see a wide divide between countries with tools to fight a pandemic and those without.
It is time for another global push to save lives. We must protect everyone, everywhere, from today’s deadliest infectious diseases as well as from future yet-unseen pathogens.